No Data
Comment on Zhongke Jiangnan (301153) 2025 Annual Report and 2026 Q1 Report: Performance Recovery and Digital Vouchers Await Expectations
The company released its annual report for 2025 and the first-quarter report for 2026. In 2025, the company achieved operating revenue of 827 million yuan, representing a year-on-year increase of 0.32%; net profit attributable to shareholders reached 101 million yuan, reflecting a year-on-year decrease of 3%.
ZKJN (301153): Strong performance in electronic payment revenue, with significant growth in 1Q26 income.
Performance Review: The company's revenue and profit for 2025 met market expectations; 1Q26 profit exceeded market expectations. The company announced its financial results for 2025 and 1Q26: 2025 revenue was RMB 827 million, a year-on-year increase of 0.32%;
Jiangnan Technology (301153): Q1 2026 performance continues the recovery trend from Q4 2025.
ZKJN released its Q1 report, achieving revenue of 99 million yuan (yoy+14.78%) in Q1 2026, with a net loss attributable to shareholders of 25.0675 million yuan, representing a year-on-year reduction in losses of 45.19%; non-recurring net loss amounted to 25.6617 million yuan.
Sino-Science Jiangnan: First Quarter Report for 2026
ZKJN (301153) Initial Coverage: Electronic Receipts as the Core, Leader in Fiscal IT
Report Summary: Zhongke Jiangnan is a leading supplier in the fiscal IT market, providing electronic payment and smart fiscal services. It has proactively laid out strategies in digital currency and data elements while actively exploring AI-enabled applications within the fiscal IT domain. Key investment highlights: Initial
ZKJN (301153): Strong performance in electronic payment revenue; 4Q25 results show rapid growth
The company's revenue and profit for 2025 fell below our expectations. According to the 2025 annual report, revenue reached 827 million yuan, a year-on-year increase of 0.32%; net profit attributable to shareholders was 101 million yuan, a year-on-year decrease of 3.42%. Both revenue and profit were lower than anticipated.